2022 International Congress Archives - Page 134 of 153

Objective and easily performed assessment of fine motor skills to support the differential diagnosis of Parkinson’s disease and other movement disorders with tremor

C. Papasavvas, R. Zietsma, S. Dodds, L. Cluitmans, A. Deutschlander, R. Walker (Edinburgh, United Kingdom)
Occlusal Stabilization Appliance on treatment of cervical dystonia

M. Salari, M. Etemadifar (Tehran, Islamic Republic of Iran)
Occupational Therapy for People with Parkinson’s Disease: A SWOT Analysis

A. Cavaglion, M. Duvdevani, N. Siegelman, R. Kizony, G. Yogev-Seligmann (Haifa, Israel)
OCEAN Study in Parkinson’s Disease: Status Update of a Randomised Double-Blind Placebo-Controlled Trial of Opicapone

K. Chaudhuri, P. Odin, J. Ferreira, A. Antonini, O. Rascol, M. Kurtis, A. Storch, K. Bannister, R. Costa, D. Magalhães, J-F. Rocha, P. Soares-da-Silva (London, United Kingdom)
Ocular ping pong movement to disentangle apathy from Bradykinesia in Parkinson’s disease

F. Rey, A. Zacharia, P. Krack, D. Benis, M. Bereau, R. Ptak, G. Allali, J. Bally (Geneva, Switzerland)
Olfactory dysfunction in patients with Huntington disease

J. Patino, H. Coco, S. Zadegan, S. Chandra, N. Karagas, N. Rocha, K. Anderson, A. Teixeira, E. Furr Stimming (Houston, USA)
Olfactory Network Reorganization in Parkinson’s Disease

L. Pesantez Pacheco, M. Saqib, D. Ehrlich, M. Hallett, S. Horovitz (Bethesda, USA)
Oligomeric alpha-synuclein in reflex tears and retinal changes in Parkinson’s disease

A. Camacho-Ordonez, M. Rodriguez-Violante, A. Cervantes-Arriaga, A. Hernández-Medrano, S. Somilleda-Ventura, H. Perez-Cano, O. Guerrero-Berger (Mexico, Mexico)
Open-Label, Single-Arm, Exploratory Trial of Opicapone: Status Update of the OASIS (OPICAPONE IN SLEEP DISORDER) Study

R. Costa, J. Ferreira, D. Magalhães, J-F. Rocha, P. Soares-da-Silva (Coronado, Portugal)
OPICAPONE ADD-ON THERAPY IN LEVODOPA-CARBIDOPA INTESTINAL GEL INFUSION: which patient might benefit the most?

F. Colucci, V. Rispoli, V. Tugnoli, M. Pugliatti, G. Tecilla, M. Sensi (Ferrara, Italy)
Opicapone Improves Global Non-Motor Symptoms Burden in Parkinson´s Disease: An Open-label Prospective Study

D. Santos García, G. Fernández Pajarín, J. Oropesa Ruíz, F. Escamilla Sevilla, R. Rahim Lopez, G. Muñoz Enríquez (A Coruña, Spain)
Opicapone use in patients with Parkinson’s disease with motor fluctuations: experience from a tertiary center

E. Ojeda-Lepe, L. Muñoz-Delgado, S. Jesús, AD. Adarmes-Gómez, D. Macías-García, MV. Jiménez Jaraba, B. Benítez Zamora, F. Carrillo, P. Mir (Seville, Spain)
Opsoclonus-Myoclonus Syndrome in Subacute Sclerosing Panencephalitis: Antibodies and Cytokine Response

D. Labunskiy, S. Kiryukhina, V. Podsevatkin (Saransk, Russian Federation)
Optimization of a neuromelanin MRI protocol for use in a longitudinal study of substantia nigra depigmentation in early Parkinson’s Disease (the InsIght-PD study)

T. Hayat, S. Pszczolkowski, Y. Xing, C. Tench, P. Morgan, J. Evans, D. Auer (Nottingham, United Kingdom)
Optimizing patient-centric clinical outcome assessments for use in Parkinson’s disease clinical trials: Critical Path for Parkinson’s multistakeholder initiative

R. Speck, D. Trundell, J. Cedarbaum, M. Campbell, P. Chin, S. Crawford, T. Dam, D. Dexter, A. Goldfine, K. Klapper, C. Kopil, S. Lee, K. Marek, H. Matthews, T. Mestre, T. Morel, M. Minchik, M. Müller, K. Schroeder, T. Simuni, G. Stebbins, C. Yan, ML. Zeissler, D. Stephenson (Tucson, USA)
Oro-bucco-lingual dyskinesia as a side effect of methotrexate therapy

H. Sarac, F. Borovecki, I. Sarac, N. Henigsberg (Zagreb, Croatia)
Oropharyngeal Dysphagia Before and After Botulinum Toxin Injection in Cervical Dystonia

A. Silbergleit, L. Schultz, K. Isabell, J. Turnbull, E. Boettcher, R. Konnai, C. Sidiropoulos, N. Patel (West Bloomfield, USA)
Oscillatory activity of pause-burst STN neurons shows an association with motor symptoms of Parkinson’s disease

E. Belova, V. Filyushkina, I. Dzhalagoniia, A. Gamaleya, A. Tomskiy, A. Sedov (Moscow, Russian Federation)
Outcome and mortality of hospital admission with COVID-19 in parkinsonian syndromes

L. Sorrell, A. Barnett, A. King, J. Inches, J. Rideout, J. Sneyd, C. Kobylecki, K. Chaudhuri, R. Walker, H. Martin, K. Stevens, S. Campbell, C. Carroll (Plymouth, United Kingdom)
Outcome measurement and goal setting recommendations in the multipattern treatment of shoulder spasticity with botulinum neurotoxin

J. Jacinto, A. Camões Barbosa, S. Carda, D. Hoad, J. Wissel (Alcabideche, Portugal)
Outcome prediction using fractional anisotropy map immediately just after magnetic resonance-guided focused ultrasound surgery for essential tremor

K. Iijima, H. Yokota, M. Nakano, T. Yamaguchi, F. Maki, S. Hino, M. Takasaki, H. Iwamuro, T. Uno (Kangawa, Japan)
Outcomes after Deep Brain Stimulation (DBS) surgery in patients with young-onset Parkinson’s disease

L. Jackson, B. Klassen, K. Lee, K. Miller, A. Hassan, R. Savica (Rochester, USA)
Outcomes of surgical management of pelvic floor dysfunction in women with Parkinson’s disease

D. Mohanty, A. Gupta, D. Sheyn, J. Gaskins, A. Mahajan (Louisville, USA)
Overnight stimulation: a new rescue strategy for deep brain stimulation-induced bradykinesia in dystonia?

N. Pozzi, T. Binder, F. Avantaggiato, I. Isaias, J. Volkmann, P. Capetian (Wuerzburg, Germany)